Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients

Kevin D. He,Syed Suhaib Naqvi,Vanessa L. Cowan,Conor M. Stack,Carolyn D. Alonso,Barbra M. Blair
DOI: https://doi.org/10.1111/ctr.15285
2024-03-23
Clinical Transplantation
Abstract:Bloodstream infections (BSIs) account for 18% of bacterial infections in the first year after solid organ transplantation (SOT). Enterococcus accounts for up to 20% of BSIs in this population, with vancomycin‐resistant enterococcus (VRE) posing a particular risk. This is a retrospective, case‐control study of adult liver and kidney transplant recipients between 01/01/2016 and 06/30/2021 that characterizes the epidemiology and outcomes of enterococcal BSIs in liver and kidney transplantations at a single institution. Subjects with an enterococcal BSI within the first 6 months post‐transplant were compared to those with non‐enterococcal BSIs in the same period. We identified 26 subjects with enterococcal BSIs and 28 controls with non‐enterococcal BSIs (n = 54; 10.3%). Cases were mostly liver transplant recipients (n = 20; 77%) with a median MELD at transplant of 33 (range 14–43); controls included 14 KT recipients (50%). Groups differed significantly (all p
surgery,transplantation
What problem does this paper attempt to address?